Bio-Modeling Systems: The Mechanisms-Based Mecidicine Company
  • 2018: PRESS-RELEASE: Paris  July17, 2018: World's first: The French Chronic Fatigue Syndrome Association decides to clinically evaluate the ME/CFS pathogenesis model produced by Bio-Modeling Systems

  • 2018: ANNOUNCEMENT: Paris May 28, 2018 Bio-Modeling Systems est heureuse de vous informer sur ses interventions lors des conférences suivantes

  • 2018: ANNOUNCEMENT: Paris June 19-20, 2018: BMSystems invited to the Micorbiotes conference organised by Adebiotech to present its microbiota vision and CADI Discovery programs 

  • 2018: ANNOUNCEMENT: Paris June 14, 2018: BMSystems invited to the Connected Health Conference organised by ANRT to present its Real life data strategy with its "patients & HCP digital pathways" partner Bolero

  • 2018: ANNOUNCEMENT: Paris March 13-14, 2018: BMSystems invited to the Epigentic conference organised by Adebiotech to present its CADI Discovery program EPIGEN-DIAB with the Centrer of excelllence in Eipgenetic in India

  • 2017: PRESS-RELEASE: Paris-November 16, 2017: BMSystems is selected to pitch at the “Translational Neurosciences Conference” organized by “NeurATRIS” and supported by “eartis” the European Infrastructure For Translational Medicine, comprising more than 80 leading European Institutes.

  • 2017: PRESS-RELEASE: Paris-New-York October 4, 2017: BMSystems, with its 14 independently validated successes to date, is selected by the Galien Foundation for the MedStartUp Award 2017 program first step during the US Galien Prize Forum in New-York.
     
  • 2017: ANNOUNCEMENT: Latest news:  Press-release from Hospices Civils de Lyon about phage therapy success with Pherecydes Pharma bacteriophages. Pherecydes-Pharma, is BMSystems’ first therapeutic spin-off.
     

Bio-Modeling Systems: The Mechanisms-Based Mecidicine Companys

BMSystems collaborative Network

BMSystems collaborative scientific and business network (past, present non-confidential extract)

  • Pharma companies: (confidential).
  • Cosmetic companies: (confidential).
  • Biotech, Medical devices, Diagnostic companies: (Confidentail)
  • CEA Life Sciences: CEA iMETI [Institute of emerging diseases and innovative therapy]  France
  • Persistent Systems Pune India
  • Persisent Systems SAS (France)
  • Max Planck Institute of Psychiatry of Munich Germany.
  • Ludwig Maximilian University Neuro-cognitive psychology of Munich Germany
  • Fondation FondaMental (Scienctific cooperation foundation) Mental illnesses France
  • University of Milan Milan Italy
  • Kayentis: The provider of the first "Digital Pen and Paper technology  2.0", the universal platform delivering "contextualized" information.
  • BioPhys-Solutions: Pioneer in innovative physical formulation of biotechnological products
  • Biocitech: Technology Park.
  • Pherecydes-Pharma: Our first spin-off. Antibacterial agents
  • Amarokbiotech: Synthon's program partner
  • ARD: (Agro-industries Research & Development) leading Industrial Biotech research company in the industrial biotech world class cluster in France.
  • IBT: (Troyes Institute of Biotechnologies). Technological transfer institute.
  • CVG: Chemistry company based in Picardie for "green" sourcing research.
  • L'Oréal: World leader in the cosmetic market. Synthon's program partner.
  • Rhodia: Major actor in the fine chemicals market (former Aventis fine chemical business). Synthon's program partner.
  • Arkema: Major actor in the chemistry market (former Total chemical business) Synthon's program partner
Bio-Modeling Systems: a leading Integrative Heuristic Systems Biology / Predictive Integrative Biology Mechanisms-Based Medicine company that delivers